Eli Lilly (NYSE:LLY) reported positive results from an open-label study of its drug Omvoh in the treatment of moderately to severely active Crohn's disease. The study, called VIVID-2, showed that the ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, while foods high in insoluble fiber, processed meat, spicy foods, dairy, and ...
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
What causes cancer? The 12 most dangerous things you can do for your health - Dr Liz O’Riordan, a breast cancer surgeon and ...
Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...
It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more ...
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
People with inflammatory bowel disease (IBD), such as Crohn’s and ulcerative colitis, are known to have an increased chance of bowel cancer, but not all will develop it. Now, a study, funded by Cancer ...
About 500,000 people in the UK live with inflammatory bowel disease (IBD), including Crohn's and ulcerative colitis.
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Ulcerative colitis (UC) symptoms may include abdominal pain, cramping, and diarrhea. People can experience periods of remission followed by flare-ups, which can lead to treatment changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback